🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Individualized ANH for Non-cardiac Surgery

RecruitingNAAges 18 Years - 75 YearsAllWest China Hospital
NCT06399536 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this trial, we proposed an individualized acute normovolemic hemodilution (ANH), and conduct a randomized controlled trial to testify the effect of individualized ANH on red cells requirement for non-cardiac surgeries with anticipating major blood loss in adults.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients undergoing elective non-cardiac surgery with an anticipated red blood cells transfusion \>8 units (or 1600ml) * Aged 18\~75 years * Preoperative Hb level \> 120g/L for men and \> 110g/L for women. Exclusion Criteria: * Refusal of blood transfusion * Cardiopulmonary insufficiency * Cerebrovascular disease * Renal impairment * Hemoglobinopathies or blood system diseases * Other situations not suitable for inclusion in clinical trial.
💊

What it tests

  • Individualized ANH
📍

Where

1 site
West China Hospital of Sichuan University
Chengdu, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy